Clinical Trials Browser

Phase 3 × OTHER × Chemotherapy-Related Cognitive Impairment × Clear all

NCT06950190 2025-08-12

(ECCPC)

Phase 3 Enrolling by invitation

Chemotherapy-Related Cognitive Impairment, Neurotoxicity Syndromes, Cognitive Dysfunction

NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Phase 3 Terminated

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms